Yitian Wu

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Prostate Cancer

Positron Emission Tomography

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Yitian Wu, Xiaojun Zhang, Xiaojiang Duan, Xing Yang, Feng Wang, Jinming Zhang
Optimized Therapeutic 177 Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Yitian Wu, Xiaojun Zhang, Ying Zhang, Baixuan Xu, Jiahe Tian, Jinming Zhang
Optimized 68 Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
Yitian Wu, Xiaojun Zhang, Xiaojiang Duan, Xing Yang, Feng Wang, Jinming Zhang
Optimized Therapeutic 177 Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Yitian Wu, Xiaojun Zhang, Xiaojiang Duan, Xing Yang, Feng Wang, Jinming Zhang
Optimized Therapeutic 177 Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Yitian Wu, Xiaojun Zhang, Xiaojiang Duan, Xing Yang, Feng Wang, Jinming Zhang
Optimized Therapeutic 177 Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)